Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis

PHASE4CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
SchizophreniaPsychoses
Interventions
BEHAVIORAL

Supportive management

The needs-focused intervention could include psychoeducation, crisis intervention, family counselling and assistance with education or work-related difficulties, according to need. Regular psychotherapy was not permitted.

DRUG

Amisulpride

Daily doses could range from 50 to 800 mg, with increments of 50 mg at first step and 100 mg at further steps. As a guideline, it was suggested that the dosage be increased as long as attenuated or brief limited intermittent positive symptoms were present. The interval between such steps should be at least 14 days if brief limited symptoms were absent and the APS score had improved.

Trial Locations (1)

50924

Department of Psychiatry and Psycotherapy University of Cologne, Cologne

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

German Federal Ministry of Education and Research

OTHER_GOV

collaborator

German Research Network On Schizophrenia

NETWORK

collaborator

Sanofi-Synthelabo

INDUSTRY

collaborator

Department of Psychiatry University of Bonn

OTHER

collaborator

Heinrich-Heine University, Duesseldorf

OTHER

collaborator

Ludwig-Maximilians - University of Munich

OTHER

lead

University of Cologne

OTHER